Adjuvant cancer therapy
Showing 26 - 50 of >10,000
Breast Cancer Trial in Istanbul (MYOVOLT (MyovoltTM, Myovolt Limited, Christchurch, New Zealand ) wearable vibration therapy
Recruiting
- Breast Cancer
- MYOVOLT (MyovoltTM, Myovolt Limited, Christchurch, New Zealand ) wearable vibration therapy device
- Home based exercise
-
Istanbul, TurkeyProfessor Cemil Taşcıoğlu Training and Research Hospital
Jan 10, 2023
Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)
Not yet recruiting
- Breast Cancer Female
- Triple Negative Breast Cancer
- quercetin, EGCG, metformin , zinc
- (no location specified)
Dec 23, 2022
Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)
Recruiting
- Breast Cancer
- Capecitabine+endocrine therapy
- Placebo+endocrine therapy
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 19, 2022
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)
Recruiting
- Colo-rectal Cancer
- adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
-
Beijing, China/Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023
Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,
Not yet recruiting
- Breast Cancer
- TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
- Placebo capsules, Letrozole, Anastrozole, Tamoxifen
-
Beijing, Beijing, China
- +1 more
Mar 10, 2023
NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- Befotertinib + Icotinib placebo
- Icotinib + Befotertinib placebo
-
Beijing, China
- +2 more
Sep 20, 2023
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +5 more
- (no location specified)
Jul 11, 2023
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)
Not yet recruiting
- Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Giredestrant
- +6 more
- (no location specified)
Sep 26, 2023
Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
- BNT321 Dose Level 1
- +3 more
- (no location specified)
Sep 29, 2023
Early-stage HER2-positive Breast Cancer, Treated With Neratinib
Recruiting
- Breast Cancer
- +2 more
-
Bouge, BelgiumClinique Saint-Luc Bouge
Oct 25, 2022
Huaier Granules in Postoperative Adjuvant Therapy for Non-small
Not yet recruiting
- Non-small Cell Lung Cancer
- Huaier granule
- Control
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Oct 27, 2023
Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)
Recruiting
- Esophageal Carcinoma
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 20, 2023
Stereotactic Body Radiation Therapy Trial in Beijing (drug adjuvant therapy)
Not yet recruiting
- Stereotactic Body Radiation Therapy
- drug adjuvant therapy
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology Cancer Center, Peking Universit
Jun 6, 2022
Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in
Not yet recruiting
- Liver Transplant; Complications
- +3 more
- multi-kinase inhibitors in combination with bevacizumab
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Gastric Cancer Trial in Xi'an (Carrelizumab combined with XELOX)
Recruiting
- Gastric Cancer
- Carrelizumab combined with XELOX
-
Xi'an, Shanxi, ChinaWang Nan
Feb 6, 2023
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +4 more
- (no location specified)
Mar 7, 2023
Breast Cancer Trial in Shanghai (The RJBC-APP, Routine post-surgical follow-up)
Not yet recruiting
- Breast Cancer
- The RJBC-APP
- Routine post-surgical follow-up
-
Shanghai, Please Select, ChinaXiaosong Chen
Jun 26, 2023
Esophagus Cancer Trial in Tianjin (Camrelizumab, Paclitaxel, Cisplatin)
Recruiting
- Esophagus Cancer
- Camrelizumab
- +2 more
-
Tianjin, Tianjin, ChinaAffiliated Cancer Hospital of Tianjin Medical University
Nov 24, 2022
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant
Not yet recruiting
- Breast Cancer
- +5 more
- Breast Surgery (BCS or mastectomy) with TAD/SNB
- Adjuvant Radiation Therapy
- (no location specified)
Oct 24, 2023
Non Small Cell Lung Cancer Trial in Innsbruck (neoadjuvant therapy with Pembrolizumab/Lenvatinib, Surgery, Adjuvant Treatment
Recruiting
- Non Small Cell Lung Cancer
- neoadjuvant therapy with Pembrolizumab/Lenvatinib
- +2 more
-
Innsbruck, Tirol, AustriaMedical University Innsbruck
Aug 23, 2022
NSCLC, Stage II-IIIA, Immunotherapy Trial in Shanghai (Serplulimab and Chemotherapy)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Serplulimab and Chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 27, 2023